Page last updated: 2024-10-27

gabexate and Transfusion Reaction

gabexate has been researched along with Transfusion Reaction in 1 studies

Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.

Transfusion Reaction: Complications of BLOOD TRANSFUSION. Included adverse reactions are common allergic and febrile reactions; hemolytic (delayed and acute) reactions; and other non-hemolytic adverse reactions such as infections and adverse immune reactions related to immunocompatibility.

Research Excerpts

ExcerptRelevanceReference
" The patient received a continuous infusion of gabexate mesilate at 60 mg x hr(-1) starting about 1 hr after the induction of anesthesia."7.76[Case of hyperkalemia possibly caused by gabexate mesilate]. ( Doi, T; Goto, T; Kurahashi, K, 2010)
" The patient received a continuous infusion of gabexate mesilate at 60 mg x hr(-1) starting about 1 hr after the induction of anesthesia."3.76[Case of hyperkalemia possibly caused by gabexate mesilate]. ( Doi, T; Goto, T; Kurahashi, K, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Doi, T1
Kurahashi, K1
Goto, T1

Other Studies

1 other study available for gabexate and Transfusion Reaction

ArticleYear
[Case of hyperkalemia possibly caused by gabexate mesilate].
    Masui. The Japanese journal of anesthesiology, 2010, Volume: 59, Issue:2

    Topics: Anesthesia; Female; Gabexate; Humans; Hyperkalemia; Intraoperative Complications; Liver Transplantat

2010